| Madison Elizabeth Rankin, MS, CF-SLP | |
|
422 N Northwest Hwy Ste 210, Park Ridge, IL 60068-3273 | |
| (847) 699-9757 | |
| (847) 696-3626 |
| Full Name | Madison Elizabeth Rankin |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 422 N Northwest Hwy Ste 210, Park Ridge, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003475740 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 242005298 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Madison Elizabeth Rankin, MS, CF-SLP 422 N Northwest Hwy Ste 210, Park Ridge, IL 60068-3273 Ph: (847) 699-9757 | Madison Elizabeth Rankin, MS, CF-SLP 422 N Northwest Hwy Ste 210, Park Ridge, IL 60068-3273 Ph: (847) 699-9757 |
News Archive
Valeant Pharmaceuticals International, Inc. announces fourth quarter financial results for 2013.
Researchers wondered if pay-for-performance (P4P) programs, which reward hospitals for meeting quality targets, have unintentional effects on racial and/or ethnic disparities. Using federal patient-level quality data, researchers found that "many hospitals treat Whites and minorities equitably" but they noted that since many minorities tend to seek care at hospitals that "perform poorly on common quality score composites, the pay for performance efforts could unintentionally penalize hospitals serving high numbers of minorities.
A team of researchers from The Wistar Institute has identified a protein that could serve as a target for reprogramming immune system cells exhausted by exposure to chronic viral infection into more effective "soldiers" against certain viruses like HIV, hepatitis C, and hepatitis B, as well as some cancers, such as melanoma.
PharmaDirections congratulates Orexigen Therapeutics on achieving FDA Advisory Board approval for their anti-obesity drug Contrave™. PharmaDirections is proud to have been Orexigen's pharmaceutical development partner and to have developed and produced the first Contrave™ product to undergo full clinical development.
Researchers have found the first direct proof that a key protein drives the clogging of arteries in two ways, and that lowering levels of it opens them up, according to study results published in the June edition of the journal Circulation.
› Verified 2 days ago
Brenda Mullan Eberline, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 535 N Hamlin Ave, Park Ridge, IL 60068 Phone: 847-858-5350 | |
Camille Ponce Kasprzak, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1675 Dempster St, Park Ridge, IL 60068 Phone: 847-723-4532 Fax: 847-723-4540 | |
Grace Ann Malone, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 924 Austin Ave, Park Ridge, IL 60068 Phone: 847-848-5499 | |
Kimberly Ann Jastremski, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 508 N. Greenwood Ave, Park Ridge, IL 60068 Phone: 224-251-0950 | |
Anna Chester, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 422 N Northwest Hwy Ste 210, Park Ridge, IL 60068 Phone: 847-699-9757 | |
Ms. Mary Colleen Burke, M.S.CCCSLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1675 Dempster St Fl 3, Park Ridge, IL 60068 Phone: 847-318-9330 |